Zalogina Anna Nikolaevna

Russian Federation

Female

municipal district Shchukino, Shchukinskaya st. 6-3 (Business address), Moscow, Russian Federation

INN: 312324772502

EU

Owner and CEO of Pharmirus LLC

Anna Zalogina is a Russian businessperson and owner and CEO of Pharmirus LLC, a Russian pharma company. In April 2025, Pharmirus LLC was the Beneficiary of Decree № 213 issued by the President of the Russian Federation, according to which the Russian company Nizhpharm, which was at the time owned by the Luxemburgian Nidda Lynx and until November 2023 owned by the German pharma company Stada AG, was put under the provisional administration of Pharmirus LLC. As the head and founder of Pharmirus LLC, Anna Zalogina has therefore benefitted from a compulsory transfer of control by the Government of the Russian Federation through laws, regulations, other legislative instruments of an entity previously owned or controlled by entities established in the Union, without the consent of the Union entities which previously owned or controlled them.

CH

Art. 15 para. 1 and 4 (Financial sanctions) and art. 29 para. 1 (Travel ban), annexe 8

Function: Owner and CEO of Pharmirus LLC; INN: 312324772502

2026-05-22

CH

Ordinance of 4 March 2022 on measures related to the situation in Ukraine (SR 946.231.176.72)

Switzerland country specific

Russia

Asset freeze, Travel ban, Trade sanctions, Financial restrictions, Transport restrictions, Other restrictions

Switzerland imposes these sanctions under the Ordinance of 4 March 2022 on measures related to the situation in Ukraine (SR 946.231.176.72). The measures follow the sanctions adopted by the European Union.